Document is current
Any future updates will be listed below
-
Authors
Hong, Theodore S.
Grassberger, Clemens
Yeap, Beow Y.
Jiang, Wenqing
Wo, Jennifer Y.
Goyal, Lipika
Clark, Jeffrey W.
Crane, Christopher H.
Koay, Eugene J. https://orcid.org/0000-0001-7675-3461
Dima, Simona
Eyler, Christine E.
Popescu, Irinel
DeLaney, Thomas F.
Zhu, Andrew X.
Duda, Dan G.
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P01-CA080124, Proton Beam/Federal Share, Proton Beam/Federal Share)
National Cancer Institute Proton Beam/Federal Share
EEA-JRP-Romania-Norway no. 4SEE
- License Information
-
More Information
Article History
Received: 1 June 2018
Revised: 30 August 2018
Accepted: 4 September 2018
First Online: 18 October 2018
Competing interests
: E.J.K. received research funding from Philips Healthcare, GE Healthcare; royalties for a book, Taylor and Francis; and consulting fees, Augmenix. D.G.D. received honoraria from Bristol-Myers Squibb; consulting fees from Bayer, Tilos, and twoXAR; and research funding from Merrimack, Leap Therapeutics, Bayer, Bristol-Myers Squibb, and Exelixis. No reagents or funding from these companies were used in the study reported here. The other authors declare no competing interests.
